Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.
Frequently asked questions
What sector does Abattis Bioceuticals Corp (ATTBF) operate in?
Abattis Bioceuticals Corp belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Abattis Bioceuticals Corp (ATTBF) current stock price?
As of the latest data, Abattis Bioceuticals Corp stock price is $0.00, with a previous close of $0.00.
What is Abattis Bioceuticals Corp (ATTBF) current market capitalization?
Abattis Bioceuticals Corp market cap is approximately 14.33 thousand.
Does Abattis Bioceuticals Corp (ATTBF) pay dividends?
No. Abattis Bioceuticals Corp does not pay a dividend.
What is Abattis Bioceuticals Corp (ATTBF) beta (volatility) score?
Abattis Bioceuticals Corp has a beta of -49.032, indicating lower volatility than the overall market.